Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $112
Portfolio Pulse from Benzinga Newsdesk
Canaccord Genuity analyst Jon Young maintains a Buy rating on Merit Medical Systems (MMSI) and raises the price target from $102 to $112.
February 29, 2024 | 1:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Canaccord Genuity maintains a Buy rating on Merit Medical Systems and raises the price target from $102 to $112.
The increase in price target by Canaccord Genuity reflects a positive outlook on Merit Medical Systems, likely due to strong performance or future growth prospects. This upgrade can instill confidence in investors, potentially leading to a short-term increase in stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100